Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated

被引:36
|
作者
Chung, CS
Wang, WY
Chaudry, IH
Ayala, A
机构
[1] Rhode Isl Hosp, Surg Res Ctr, Providence, RI 02903 USA
[2] Brown Univ, Sch Med, Surg Res Ctr, Providence, RI 02912 USA
[3] Brown Univ, Sch Med, Dept Surg, Providence, RI 02912 USA
关键词
cecal ligation and puncture; programmed cell death; Fas ligand-deficient mouse;
D O I
10.1152/ajpgi.2001.280.5.G812
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recent studies from our laboratory demonstrated that mucosal lymphoid tissue such as Peyer's patch cells and lamina propria (LP) B lymphocytes from mice shows evidence of increased apoptosis after sepsis that is associated with localized inflammation/activation. The mechanism for this is poorly understood. Endotoxin as well as Fas/Fas ligand (FasL) have been shown to augment lymphocyte apoptosis; however, their contribution to the increase of apoptosis in LP B-cells during sepsis is not known. To study this, sepsis was induced by cecal ligation and puncture (CLP) in endotoxin-tolerant C3H/HeJ or FasL-deficient C3H/HeJ-FasL(gld) (FasL(-)) mice and LP lymphocytes were isolated 24 h later. Phenotypic, apoptotic, and functional indexes were assessed. The number of LP B cells decreased markedly in C3H/HeJ mice but not in FasL- deficient animals at 24 h after CLP. This was associated with comparable alteration in apoptosis and Fas antigen expression in the B cells of these mice. Septic LP lymphocytes also showed increased IgA production, which was absent in the FasL- deficient CLP mice. Furthermore, Fas ligand deficiency appeared to improve survival of septic challenge. These data suggest that the increase in B cell apoptosis in septic animals is partially due to a Fas/FasL-mediated process but not endotoxin.
引用
收藏
页码:G812 / G818
页数:7
相关论文
共 50 条
  • [1] Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process
    Ayala, A
    Xu, YX
    Ayala, CA
    Sonefeld, DE
    Karr, SM
    Evans, TA
    Chaudry, IH
    BLOOD, 1998, 91 (04) : 1362 - 1372
  • [2] Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin
    Ayala, A
    Chung, CS
    Xu, YX
    Evans, TA
    Redmond, KM
    Chaudry, IH
    IMMUNOLOGY, 1999, 97 (01) : 45 - 55
  • [3] Sepsis induces increased apoptosis in lamina propria mononuclear cells which is associated with altered cytokine gene expression
    Chung, SC
    Xu, YX
    Chaudry, IH
    Ayala, A
    JOURNAL OF SURGICAL RESEARCH, 1998, 77 (01) : 63 - 70
  • [4] Does FAS ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis?
    Ayala, A
    Xu, YX
    Chung, CS
    Chaudry, IH
    SHOCK, 1999, 11 (03): : 211 - 217
  • [5] Sepsis induces increased apoptosis in lamina propria mononuclear cells which is associated with altered cytokine gene expression.
    Chung, CS
    Xu, YX
    Chaudry, IH
    Avala, A
    FASEB JOURNAL, 1998, 12 (05): : A881 - A881
  • [6] Endotoxin contamination in isolation of lamina propria mononuclear cells
    Fukushima, K
    Sasaki, I
    Takahashi, K
    Naito, H
    Funayama, Y
    Matsuno, S
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 187 (01): : 37 - 42
  • [7] T regulatory cells are increased during murine polymicrobial sepsis
    Efron, PA
    Scumpia, PO
    Matsumoto, T
    Ungaro, R
    Moldawer, LL
    SHOCK, 2004, 21 : 53 - 53
  • [8] The hepatic microvascular alterations in polymicrobial sepsis are not mediated by bacterial endotoxin
    Singer, G
    Granger, DN
    FASEB JOURNAL, 2006, 20 (04): : A704 - A704
  • [9] Human lamina propria T cells (LPT) manifest enhanced Fas-mediated apoptosis
    Boirivant, M
    Pica, R
    DeMaria, R
    Testi, R
    Pal, F
    Pallone, F
    Strober, W
    FASEB JOURNAL, 1996, 10 (06): : 403 - 403
  • [10] Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis
    Boirivant, M
    Pica, R
    DeMaria, R
    Testi, R
    Pallone, F
    Strober, W
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11): : 2616 - 2622